ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.738,05
0,02%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Amphastar Pharmaceuticals Inc (AMPH)

  7. Amphastar Pharmaceuticals Inc (AMPH) Notícias

AMPH

Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMPH
DataHoraFonteTítuloCódigoCompanhia
08/05/202417:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMPHAmphastar Pharmaceuticals Inc
08/03/202418:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
01/03/202418:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
29/02/202418:53Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/02/202419:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
08/11/202318:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
12/09/202313:10Dow Jones NewsAmphastar Pharmaceuticals Shares Down 9% After Private Notes OfferingNASDAQ:AMPHAmphastar Pharmaceuticals Inc
16/08/202318:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
21/06/202318:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
15/06/202317:08Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
06/06/202307:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/05/202317:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/04/202308:42Dow Jones NewsEli Lilly to Sell Baqsimi Product to AmphastarNASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/04/202307:45PR Newswire (US)Lilly to Divest BAQSIMI to AmphastarNASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202317:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202317:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
01/03/202318:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/02/202313:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/08/202207:55TipRanksNeedham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/06/202215:05TipRanksAmphastar Pharmaceuticals (AMPH) Receives a Hold from NeedhamNASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/05/202213:25TipRanksNeedham Maintains a Hold Rating on Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202217:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
13/04/202212:35TipRanksNeedham Maintains Their Hold Rating on Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
08/04/202211:45TipRanksAmphastar Pharmaceuticals (AMPH) Gets a Hold Rating from NeedhamNASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/11/202118:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
15/06/202117:05GlobeNewswire Inc.Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation ConferenceNASDAQ:AMPHAmphastar Pharmaceuticals Inc
27/05/202107:00GlobeNewswire Inc.Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare ConferenceNASDAQ:AMPHAmphastar Pharmaceuticals Inc
07/05/202117:05GlobeNewswire Inc.Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin SubsidiaryNASDAQ:AMPHAmphastar Pharmaceuticals Inc
06/05/202117:05GlobeNewswire Inc.Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021NASDAQ:AMPHAmphastar Pharmaceuticals Inc
03/05/202107:00GlobeNewswire Inc.Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate InjectionNASDAQ:AMPHAmphastar Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMPH

Seu Histórico Recente

BOV
B3SA3
B3 SA - Brasil Bolsa Bal... ON
BOV
BBAS3
BANCO DO BRASIL ON
COIN
ETHUSD
Ethereum
COIN
EOSBTC
EOS
DBI
DAX
DAX
NYSE
GGB
Gerdau
COIN
XLMBTC
Stellar Lumens
COIN
BRAZBTC
Brazio
BOV
ELET6
ELETROBRAS PNB
BOV
GGBR4
GERDAU PN
COIN
PLUS1BTC
PlusOneCoin
BOV
PETR3
PETROBRAS ON
BOV
PETR4
PETROBRAS PN
NYSE
RIO
Rio Tinto
COIN
XRPBTC
Ripple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados